Crystal structure analysis of HIV-1 protease mutant V82A with a substrate analog P2-NC

Molecular basis for substrate recognition and drug resistance from 1.1 to 1.6 angstroms resolution crystal structures of HIV-1 protease mutants with substrate analogs.

PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYDQIIIEIAGHKAIGTVLVGPT
PANIIGRNLLTQIGATLNF

Human immunodeficiency virus type 1 (BH5 ISOLATE)

SODIUM CHLORIDE 0.4M, DMSO 5%,CITRATE PHOSPHATE BUFFER, pH 5.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K

IN THE DEPOSITED FILE, THE INHIBITOR 2NC HAD AN EXTRA O7 ATOM IN CONFORMATION B WHICH ACCORDING TO THE AUTHORS MIGHT BE A REACTION INTERMEDIATE. ASSOCIATED PUBLICATION DOES NOT HAVE DIRECT DISCUSSION ON SUCH ATOM. THIS EXTRA O7 HAS BEEN UPDATED TO ATOM UNX101A.

ANISOTROPIC REFINEMENT REDUCED FREE R (NO CUTOFF) BY ?

HIV-1 PROTEASE, MUTANT, DIMER, SUBSTRATE ANALOG, HYDROLASE-HYDROLASE INHIBITOR COMPLEX

PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPT
PVNIIGRNLLTQIGCTLNF